Literature DB >> 29697272

Mortality Related to Chronic Obstructive Pulmonary Disease and Co-morbidities in the United States, A Multiple Causes of Death Analysis.

Jennifer Obi1, Alem Mehari1, Richard Gillum2.   

Abstract

Chronic obstructive pulmonary disease (COPD) mortality based on the underlying cause of death (UCOD) underestimates disease burden. We aimed to determine the current COPD mortality rate, trends and the distribution of co-morbidities using United States (US) multiple-cause of death (MCOD) records. All 38,905,575 death certificates of decedents aged ≥45 years in the United States were analyzed for 1999-2015. COPD was defined by ICD-10 codes J40-J44 and J47 based either on the UCOD or up to 20 contributing causes coded. Annual age-standardized COPD death rates were computed by age, gender and race/ethnicity for those with any mention of COPD. In 2015, COPD was mentioned in 11.59% (292,572 deaths) in MCOD, compared to 11.13% (243,617 deaths) in 1999, a 4% increase. However, it was reported as the UCOD for only 5.56% and 4.97% in 2015 and 1999 respectively, an 11% increase. The most common UCOD in subjects with any mention of COPD was respiratory disorders in 49% of males and 55% of females. The relative change in death rates differed between MCOD and UCOD. For example, among non-Hispanic white females aged 65-74 years the UCOD rate per 100,000 (95% CI) decreased from 163 (160-166) to 147 (145-150), average annual percent decrease (AAPD) -0.26, while the MCOD rate decreased from 308 (304-311) to 263 (260-267), AAPD -0.87. Statistics based on UCOD understated the burden of COPD in the United States. MCOD rates were twice as high as UCOD rates. The relative change in death percent or rates differed between MCOD and UCOD. MCOD analysis should be repeated periodically to help evaluate the burden of COPD-related mortality.

Entities:  

Keywords:  COPD; deaths; tobacco

Mesh:

Year:  2018        PMID: 29697272     DOI: 10.1080/15412555.2018.1454897

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  5 in total

1.  BMI moderates the association between adverse childhood experiences and COPD.

Authors:  Megan R Westmore; Priyanjali Chakraborty; LaTisha A Thomas; Lacey Jenkins; Faheem Ohri; Philip Baiden
Journal:  J Psychosom Res       Date:  2022-07-16       Impact factor: 4.620

2.  Operational Modeling with Health Economics to Support Decision Making for COPD Patients.

Authors:  Usame Yakutcan; Eren Demir; John R Hurst; Paul C Taylor; Heidi A Ridsdale
Journal:  Health Serv Res       Date:  2021-03-22       Impact factor: 3.402

3.  Association Between Health Literacy, Electronic Health Literacy, Disease-Specific Knowledge, and Health-Related Quality of Life Among Adults With Chronic Obstructive Pulmonary Disease: Cross-Sectional Study.

Authors:  Michael Stellefson; Samantha R Paige; Julia M Alber; Beth H Chaney; Don Chaney; Avery Apperson; Arjun Mohan
Journal:  J Med Internet Res       Date:  2019-06-06       Impact factor: 5.428

4.  Triple therapy for COPD: a crude analysis from a systematic review of the evidence.

Authors:  Jose Luis Lopez-Campos; Laura Carrasco-Hernandez; Esther Quintana-Gallego; Carmen Calero-Acuña; Eduardo Márquez-Martín; Francisco Ortega-Ruiz; Joan B Soriano
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

5.  Mortality Related to Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic: An Analysis of Multiple Causes of Death through Different Epidemic Waves in Veneto, Italy.

Authors:  Ugo Fedeli; Claudio Barbiellini Amidei; Alessandro Marcon; Veronica Casotto; Francesco Grippo; Enrico Grande; Thomas Gaisl; Stefano Barco
Journal:  Int J Environ Res Public Health       Date:  2022-10-07       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.